MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-11
DOI
10.1038/s41598-019-55208-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway
- (2019) Zhou Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Role of protein kinase N2 (PKN2) in cigarette smoke-mediated oncogenic transformation of oral cells
- (2018) Pavithra Rajagopalan et al. Journal of Cell Communication and Signaling
- New approach for understanding genome variations in KEGG
- (2018) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations
- (2017) Jonathan S. Brammeld et al. GENOME RESEARCH
- Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib
- (2017) Eri Banno et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MAP2K1 Mutation in Colorectal Cancer Patients: Therapeutic Challenge Using Patient-Derived Tumor Cell Lines
- (2017) J. E. Kim et al. Journal of Cancer
- Randomized trial of a short course of erlotinib 150 to 300 mg daily prior to surgery for squamous cell carcinomas of the head and neck (SCCHN) in current, former, and never smokers: Objective responses and clinical outcomes.
- (2017) W. N. William Junior et al. JOURNAL OF CLINICAL ONCOLOGY
- BioCircos.js: an interactive Circos JavaScript library for biological data visualization on web applications
- (2016) Ya Cui et al. BIOINFORMATICS
- The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia
- (2016) Hubo Li et al. BLOOD
- Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer
- (2016) Grant A. Howe et al. PLoS One
- YAP promotes erlotinib resistance in human non-small cell lung cancer cells
- (2016) Ping-Chih Hsu et al. Oncotarget
- A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
- (2016) Aneesha Radhakrishnan et al. Scientific Reports
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
- (2015) Oncotarget
- First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines
- (2015) Senthilmurugan Ramalingam et al. Oncotarget
- YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.
- (2015) Erica Lorenzetto et al. Oncotarget
- Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
- (2014) Moriah H. Nissan et al. CANCER RESEARCH
- MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking
- (2014) M. E. Arcila et al. CLINICAL CANCER RESEARCH
- An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
- (2014) Alexander S. Banks et al. NATURE
- A Novel Role for p115RhoGEF in Regulation of Epithelial Plasticity
- (2014) Swapnil S. Kher et al. PLoS One
- Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition
- (2014) Simona Coco et al. Targeted Oncology
- HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells
- (2013) J. Hun Hah et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
- (2013) Keith M. Giles et al. MOLECULAR CANCER THERAPEUTICS
- The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors
- (2013) Xiaofei Chang et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Oncogenic MAP2K1 mutations in human epithelial tumors
- (2012) Young Lim Choi et al. CARCINOGENESIS
- Attenuation of T Cell Receptor Signaling by Serine Phosphorylation-mediated Lysine 30 Ubiquitination of SLP-76 Protein
- (2012) Xiaohong Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Zyxin Is a Transforming Growth Factor-β (TGF-β)/Smad3 Target Gene That Regulates Lung Cancer Cell Motility via Integrin α5β1
- (2012) Nikica Mise et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome
- (2012) Leopold Groesser et al. NATURE GENETICS
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
- (2012) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- Decreased expression of repulsive guidance molecule member A by DNA methylation in colorectal cancer is related to tumor progression
- (2012) Hui-Jun Yang ONCOLOGY REPORTS
- Snail Controls the Mesenchymal Phenotype and Drives Erlotinib Resistance in Oral Epithelial and Head and Neck Squamous Cell Carcinoma Cells
- (2012) Miranda Dennis et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors
- (2012) Dalia Ercan et al. Cancer Discovery
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor–targeted therapy with cetuximab and gefitinib
- (2011) Rodney B. Luwor et al. CANCER LETTERS
- Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
- (2011) Sergey I Nikolaev et al. NATURE GENETICS
- Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis
- (2011) Lin Ge et al. PLoS One
- New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors
- (2010) L. F. Chen et al. CLINICAL CANCER RESEARCH
- Signalling to cancer cell invasion through PAK family kinases
- (2010) Andrew Whale Frontiers in Bioscience-Landmark
- 19q13 amplification is associated with high grade and stage in pancreatic cancer
- (2010) Riina Kuuselo et al. GENES CHROMOSOMES & CANCER
- Human Protein Reference Database and Human Proteinpedia as Discovery Resources for Molecular Biotechnology
- (2010) Renu Goel et al. MOLECULAR BIOTECHNOLOGY
- Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
- (2009) David J. McConkey et al. CANCER AND METASTASIS REVIEWS
- Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells
- (2009) S. Benavente et al. CLINICAL CANCER RESEARCH
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Prognostic Significance of Epidermal Growth Factor Receptor Phosphorylation and Mutation in Head and Neck Squamous Cell Carcinoma
- (2009) T. Hama et al. ONCOLOGIST
- Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck
- (2009) Ezra Eddy Wyssam Cohen et al. ORAL ONCOLOGY
- Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
- (2009) Ajay Matta et al. Head and Neck Optical Diagnostics Society
- Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells
- (2008) B. C. Fuchs et al. CANCER RESEARCH
- Novel MEK1 Mutation Identified by Mutational Analysis of Epidermal Growth Factor Receptor Signaling Pathway Genes in Lung Adenocarcinoma
- (2008) J. L. Marks et al. CANCER RESEARCH
- Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility
- (2008) R. J. Paccione et al. MOLECULAR CANCER THERAPEUTICS
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now